Complement-Based Drug Development Summit leaderboard
  • Tuesday, August 25, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 267

Author

Pharma Journalist 9023 posts 0 comments

SK Biopharmaceuticals, Eurofarma Enter into Licensing Agreement for Cenobamate in Latin America

Jul 15, 2022
SK Biopharmaceuticals, Co., Ltd., announced that it has entered into a licensing agreement for Eurofarma, a Brazilian pharmaceutical company with business in over 20 countries, to…
Read More...

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

Jul 15, 2022
Zymergen Inc. announced it has expanded its agreement with Octant to further scale their next-generation platform to develop breakthrough medicines. In May, Octant purchased five…
Read More...

Health Canada authorizes use of Moderna COVID-19 vaccine in children 6 months to 5 years of age

Jul 14, 2022
Today, Health Canada authorized the use of the Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. This is the first COVID-19 vaccine authorized in Canada for use…
Read More...

Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID™…

Jul 14, 2022
Codexis, Inc. announced that the Company has entered into an agreement with Pfizer for the supply of a proprietary high-performance enzyme used to manufacture a critical intermediate…
Read More...

Labcorp Launches New Test to Identify and Confirm Neurodegenerative Disease

Jul 14, 2022
Labcorp announced the launch of the first widely accessible test that provides direct evidence of neurodegeneration and neuronal injury. The new Neurofilament Light Chain…
Read More...

Orion and MSD announce global collaboration for the development and commercialisation of ODM-208, an…

Jul 14, 2022
Orion Corporation and MSD announced a global development and commercialisation agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 11A1…
Read More...

FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged…

Jul 13, 2022
Novavax, Inc. announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to…
Read More...

DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow

Jul 13, 2022
DNAnexus, Inc. and Twist Bioscience Corporation announced a collaboration aimed at accelerating research and reducing the time to design, validate, and commercialize new, high-quality,…
Read More...

AVROBIO Receives Orphan Drug Designation from the FDA for AVR-RD-05, a Gene Therapy for…

Jul 13, 2022
AVROBIO, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVR-RD-05, its gene therapy for the treatment of mucopolysaccharidosis…
Read More...

Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for…

Jul 13, 2022
Innoviva, Inc. announced that the company has entered into an agreement to sell its 15% economic stake in Theravance Respiratory Company LLC (“TRC”), which receives royalties stemming…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings
  • Lundbeck Wins EU Orphan Designation for Cushing’s Syndrome Drug
  • Takeda Wins Japan Approval for New Narcolepsy Type 1 Drug
  • GSK Wins Japan Approval for Hepatitis B Functional Cure
  • Gossamer Bio Secures Up to $250 Million for Seralutinib

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.